Phillip Schwartz - Net Worth and Insider Trading
Phillip Schwartz Net Worth
The estimated net worth of Phillip Schwartz is at least $1 Million dollars as of 2024-11-09. Phillip Schwartz is the President of R&D of Entera Bio Ltd and owns about 607,410 shares of Entera Bio Ltd (ENTX) stock worth over $1 Million. Details can be seen in Phillip Schwartz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Phillip Schwartz has not made any transactions after 2022-01-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Phillip Schwartz
Phillip Schwartz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phillip Schwartz owns 1 companies in total, including Entera Bio Ltd (ENTX) .
Click here to see the complete history of Phillip Schwartz’s form 4 insider trades.
Insider Ownership Summary of Phillip Schwartz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTX | Entera Bio Ltd | 2022-01-20 | director & President of R&D |
Phillip Schwartz Latest Holdings Summary
Phillip Schwartz currently owns a total of 1 stock. Phillip Schwartz owns 607,410 shares of Entera Bio Ltd (ENTX) as of January 20, 2022, with a value of $1 Million.
Latest Holdings of Phillip Schwartz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTX | Entera Bio Ltd | 2022-01-20 | 607,410 | 1.72 | 1,044,745 |
Holding Weightings of Phillip Schwartz
Phillip Schwartz Form 4 Trading Tracker
According to the SEC Form 4 filings, Phillip Schwartz has made a total of 1 transactions in Entera Bio Ltd (ENTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entera Bio Ltd is the acquisition of 10,000 shares on January 20, 2022, which cost Phillip Schwartz around $25,300.
Insider Trading History of Phillip Schwartz
- 1
Phillip Schwartz Trading Performance
GuruFocus tracks the stock performance after each of Phillip Schwartz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Phillip Schwartz is 20.49%. GuruFocus also compares Phillip Schwartz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Phillip Schwartz within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Phillip Schwartz's insider trading performs compared to the benchmark.
Performance of Phillip Schwartz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.34 | | | | | |
| Relative Return to S&P 500(%) | -11.35 | | | | | |
Phillip Schwartz Ownership Network
Ownership Network List of Phillip Schwartz
Ownership Network Relation of Phillip Schwartz
Phillip Schwartz Owned Company Details
What does Entera Bio Ltd do?
Who are the key executives at Entera Bio Ltd?
Phillip Schwartz is the director & President of R&D of Entera Bio Ltd. Other key executives at Entera Bio Ltd include Israel CFO Dana Yaacov-garbeli , U.S.based CFO Ramesh Ratan , and director & Chief Executive Officer Spiros Jamas .
Entera Bio Ltd (ENTX) Insider Trades Summary
Over the past 18 months, Phillip Schwartz made no insider transaction in Entera Bio Ltd (ENTX). Other recent insider transactions involving Entera Bio Ltd (ENTX) include a net purchase of 35,115 shares made by Haya Taitel , a net purchase of 43,952 shares made by Gerald M Lieberman , and a net purchase of 40,000 shares made by Sean Ellis .
In summary, during the past 3 months, insiders sold 0 shares of Entera Bio Ltd (ENTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entera Bio Ltd (ENTX) were sold and 143,019 shares were bought by its insiders, resulting in a net purchase of 143,019 shares.
Entera Bio Ltd (ENTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entera Bio Ltd Insider Transactions
Phillip Schwartz Mailing Address
Above is the net worth, insider trading, and ownership report for Phillip Schwartz. You might contact Phillip Schwartz via mailing address: C/o Entera Bio Ltd., Kiryat Hadassah, Minrav Building, 5th Fl, Jerusalem L3 9112002.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
